1887

Abstract

Recombinant measles virus (rMV) vectors expressing heterologous viral membrane protein antigens are potentially useful as vaccines. Genes encoding the mumps virus haemagglutinin-neuraminidase (MuV-HN), the influenza virus haemagglutinin (Flu-HA) or the respiratory syncytial virus fusion (RSV-F) proteins were inserted into the genome of a live attenuated vaccine strain of measles virus. Additionally, in this case rMV with the MuV-HN or the influenza HA inserts, chimeric constructs were created that harboured the measles virus native haemagglutinin or fusion protein cytoplasmic domains. In all three cases, sucrose-gradient purified preparations of rMV were found to have incorporated the heterologous viral membrane protein on the viral membrane. The possible utility of rMV expressing RSV-F (rMV.RSV-F) as a vaccine was tested in a cotton rat challenge model. Vaccination with rMV.RSV-F efficiently induced neutralizing antibodies against RSV and protected animals from infection with RSV in the lungs.

Loading

Article metrics loading...

/content/journal/jgv/10.1099/jgv.0.000523
2016-09-01
2019-08-23
Loading full text...

Full text loading...

/deliver/fulltext/jgv/97/9/2117.html?itemId=/content/journal/jgv/10.1099/jgv.0.000523&mimeType=html&fmt=ahah

References

  1. Albrecht P. , Herrmann K. , Burns G. R. . ( 1981;). Role of virus strain in conventional and enhanced measles plaque neutralization test. . J Virol Methods 3: 251–260.[PubMed] [CrossRef]
    [Google Scholar]
  2. Bolton D. L. , Santra S. , Swett-Tapia C. , Custers J. , Song K. , Balachandran H. , Mach L. , Naim H. , Kozlowski P. A. et al. ( 2012;). Priming T-cell responses with recombinant measles vaccine vector in a heterologous prime-boost setting in non-human primates. . Vaccine 30: 5991–5998. [CrossRef] [PubMed]
    [Google Scholar]
  3. Boukhvalova M. S. , Prince G. A. , Blanco J. C. . ( 2009;). The cotton rat model of respiratory viral infections. . Biologicals 37: 152–159. [CrossRef] [PubMed]
    [Google Scholar]
  4. Brandenburg B. , Koudstaal W. , Goudsmit J. , Klaren V. , Tang C. , Bujny M. V. , Korse H. J. , Kwaks T. , Otterstrom J. J. et al. ( 2013;). Mechanisms of hemagglutinin targeted influenza virus neutralization. . PLoS One 8: e80034. [CrossRef] [PubMed]
    [Google Scholar]
  5. Cantarella G. , Liniger M. , Zuniga A. , Schiller J. T. , Billeter M. , Naim H. Y. , Glueck R. . ( 2009;). Recombinant measles virus-HPV vaccine candidates for prevention of cervical carcinoma. . Vaccine 27: 3385–3390. [CrossRef] [PubMed]
    [Google Scholar]
  6. Guerbois M. , Moris A. , Combredet C. , Najburg V. , Ruffié C. , Février M. , Cayet N. , Brandler S. , Schwartz O. et al. ( 2009;). Live attenuated measles vaccine expressing HIV-1 Gag virus like particles covered with gp160DeltaV1V2 is strongly immunogenic. . Virology 388: 191–203. [CrossRef] [PubMed]
    [Google Scholar]
  7. Kim E. , Okada K. , Beeler J. A. , Crim R. L. , Piedra P. A. , Gilbert B. E. , Gambotto A. . ( 2014;). Development of an adenovirus-based respiratory syncytial virus vaccine: preclinical evaluation of efficacy, immunogenicity, and enhanced disease in a cotton rat model. . J Virol 88: 5100–5108. [CrossRef] [PubMed]
    [Google Scholar]
  8. Li M. , Schmitt P. T. , Li Z. , McCrory T. S. , He B. , Schmitt A. P. . ( 2009;). Mumps virus matrix, fusion, and nucleocapsid proteins cooperate for efficient production of virus-like particles. . J Virol 83: 7261–7272. [CrossRef] [PubMed]
    [Google Scholar]
  9. Liniger M. , Zuniga A. , Morin T. N. , Combardiere B. , Marty R. , Wiegand M. , Ilter O. , Knuchel M. , Naim H. Y. . ( 2009;). Recombinant measles viruses expressing single or multiple antigens of human immunodeficiency virus (HIV-1) induce cellular and humoral immune responses. . Vaccine 27: 3299–3305. [CrossRef] [PubMed]
    [Google Scholar]
  10. McLean H. Q. , Fiebelkorn A. P. , Temte J. L. , Wallace G. S. . Centers for Disease Control and Prevention ( 2013;). Prevention of measles, rubella, congenital rubella syndrome, and mumps, 2013: summary recommendations of the Advisory Committee on Immunization Practices (ACIP). . MMWR Recomm Rep 62: 1–34.[PubMed]
    [Google Scholar]
  11. Mok H. , Cheng X. , Xu Q. , Zengel J. R. , Parhy B. , Zhao J. , Wang C. K. , Jin H. . ( 2012;). Evaluation of measles vaccine virus as a vector to deliver respiratory syncytial virus fusion protein or Epstein-Barr virus glycoprotein gp350. . Open Virol J 6: 12–22. [CrossRef] [PubMed]
    [Google Scholar]
  12. Mourez T. , Mesel-Lemoine M. , Combredet C. , Najburg V. , Cayet N. , Tangy F. . ( 2011;). A chimeric measles virus with a lentiviral envelope replicates exclusively in CD4+/CCR5+ cells. . Virology 419: 117–125. [CrossRef] [PubMed]
    [Google Scholar]
  13. Parks C. L. , Lerch R. A. , Walpita P. , Sidhu M. S. , Udem S. A. . ( 1999;). Enhanced measles virus cDNA rescue and gene expression after heat shock. . J Virol 73: 3560–3566.[PubMed]
    [Google Scholar]
  14. Prince G. A. , Jenson A. B. , Horswood R. L. , Camargo E. , Chanock R. M. . ( 1978;). The pathogenesis of respiratory syncytial virus infection in cotton rats. . Am J Pathol 93: 771–791.[PubMed]
    [Google Scholar]
  15. Prince G. A. , Potash L. , Horswood R. L. , Camargo E. , Suffin S. C. , Johnson R. A. , Chanock R. M. . ( 1979;). Intramuscular inoculation of live respiratory syncytial virus induces immunity in cotton rats. . Infect Immun 23: 723–728.[PubMed]
    [Google Scholar]
  16. Prince G. A. , Horswood R. L. , Chanock R. M. . ( 1985;). Quantitative aspects of passive immunity to respiratory syncytial virus infection in infant cotton rats. . J Virol 55: 517–520.[PubMed]
    [Google Scholar]
  17. Radecke F. , Spielhofer P. , Schneider H. , Kaelin K. , Huber M. , Dötsch C. , Christiansen G. , Billeter M. A. . ( 1995;). Rescue of measles viruses from cloned DNA. . EMBO J 14: 5773–5784.[PubMed]
    [Google Scholar]
  18. Ramsauer K. , Schwameis M. , Firbas C. , Müllner M. , Putnak R. J. , Thomas S. J. , Desprès P. , Tauber E. , Jilma B. et al. ( 2015;). Immunogenicity, safety, and tolerability of a recombinant measles-virus-based chikungunya vaccine: a randomised, double-blind, placebo-controlled, active-comparator, first-in-man trial. . Lancet Infect Dis 15: 519–527. [CrossRef] [PubMed]
    [Google Scholar]
  19. Rennick L. J. , de Vries R. D. , Carsillo T. J. , Lemon K. , van Amerongen G. , Ludlow M. , Nguyen D. T. , Yüksel S. , Verburgh R. J. et al. ( 2015;). Live-attenuated measles virus vaccine targets dendritic cells and macrophages in muscle of nonhuman primates. . J Virol 89: 2192–2200. [CrossRef] [PubMed]
    [Google Scholar]
  20. Sawada A. , Komase K. , Nakayama T. . ( 2011;). AIK-C measles vaccine expressing fusion protein of respiratory syncytial virus induces protective antibodies in cotton rats. . Vaccine 29: 1481–1490. [CrossRef] [PubMed]
    [Google Scholar]
  21. Schwarzer S. , Reibel S. , Lang A. B. , Struck M. M. , Finkel B. , Gerike E. , Tischer A. , Gassner M. , Glück R. et al. ( 1998;). Safety and characterization of the immune response engendered by two combined measles, mumps and rubella vaccines. . Vaccine 16: 298–304. [CrossRef] [PubMed]
    [Google Scholar]
  22. Singh M. , Cattaneo R. , Billeter M. A. . ( 1999;). A recombinant measles virus expressing hepatitis B virus surface antigen induces humoral immune responses in genetically modified mice. . J Virol 73: 4823–4828.[PubMed]
    [Google Scholar]
  23. Spielhofer P. , Bächi T. , Fehr T. , Christiansen G. , Cattaneo R. , Kaelin K. , Billeter M. A. , Naim H. Y. . ( 1998;). Chimeric measles viruses with a foreign envelope. . J Virol 72: 2150–2159.[PubMed]
    [Google Scholar]
  24. Storch G. A. . ( 1998;). Humanized monoclonal antibody for prevention of respiratory syncytial virus infection. . Pediatrics 102: 648–651. [CrossRef] [PubMed]
    [Google Scholar]
  25. Tangy F. , Naim H. Y. . ( 2005;). Live attenuated measles vaccine as a potential multivalent pediatric vaccination vector. . Viral Immunol 18: 317–326. [CrossRef] [PubMed]
    [Google Scholar]
  26. Throsby M. , van den Brink E. , Jongeneelen M. , Poon L. L. , Alard P. , Cornelissen L. , Bakker A. , Cox F. , van Deventer E. et al. ( 2008;). Heterosubtypic neutralizing monoclonal antibodies cross-protective against H5N1 and H1N1 recovered from human IgM+ memory B cells. . PLoS One 3: e3942. [CrossRef] [PubMed]
    [Google Scholar]
  27. Wang Z. , Hangartner L. , Cornu T. I. , Martin L. R. , Zuniga A. , Billeter M. A. , Naim H. Y. . ( 2001;). Recombinant measles viruses expressing heterologous antigens of mumps and simian immunodeficiency viruses. . Vaccine 19: 2329–2336. [CrossRef] [PubMed]
    [Google Scholar]
  28. Welliver T. P. , Garofalo R. P. , Hosakote Y. , Hintz K. H. , Avendano L. , Sanchez K. , Velozo L. , Jafri H. , Chavez-Bueno S. et al. ( 2007;). Severe human lower respiratory tract illness caused by respiratory syncytial virus and influenza virus is characterized by the absence of pulmonary cytotoxic lymphocyte responses. . J Infect Dis 195: 1126–1136. [CrossRef] [PubMed]
    [Google Scholar]
  29. Widjojoatmodjo M. N. , Bogaert L. , Meek B. , Zahn R. , Vellinga J. , Custers J. , Serroyen J. , Radošević K. , Schuitemaker H. . ( 2015;). Recombinant low-seroprevalent adenoviral vectors Ad26 and Ad35 expressing the respiratory syncytial virus (RSV) fusion protein induce protective immunity against RSV infection in cotton rats. . Vaccine 33: 5406–5414. [CrossRef] [PubMed]
    [Google Scholar]
  30. Wu H. , Pfarr D. S. , Johnson S. , Brewah Y. A. , Woods R. M. , Patel N. K. , White W. I. , Young J. F. , Kiener P. A. . ( 2007;). Development of motavizumab, an ultra-potent antibody for the prevention of respiratory syncytial virus infection in the upper and lower respiratory tract. . J Mol Biol 368: 652–665. [CrossRef] [PubMed]
    [Google Scholar]
  31. Yamaji Y. , Nakayama T. . ( 2014;). Recombinant measles viruses expressing respiratory syncytial virus proteins induced virus-specific CTL responses in cotton rats. . Vaccine 32: 4529–4536. [CrossRef] [PubMed]
    [Google Scholar]
  32. Zuniga A. , Liniger M. , Morin T. N. , Marty R. R. , Wiegand M. , Ilter O. , Weibel S. , Billeter M. A. , Knuchel M. C. et al. ( 2013;). Sequence and immunogenicity of a clinically approved novel measles virus vaccine vector. . Hum Vaccin Immunother 9: 607–613. [CrossRef] [PubMed]
    [Google Scholar]
http://instance.metastore.ingenta.com/content/journal/jgv/10.1099/jgv.0.000523
Loading
/content/journal/jgv/10.1099/jgv.0.000523
Loading

Data & Media loading...

Most Cited This Month

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error